Patents Assigned to Lebrun Labs LLC
  • Publication number: 20240082214
    Abstract: The disclosure relates to formulations and methods for the in vitro testing of ocular irritants. It was discovered that adding an antioxidant formulation to in vitro ocular irritation tests, including for example, a biochemical ocular irritation test, a reconstituted human corneal epithelium (RhCE) ocular irritation test and an excised eye depth of injury (DoI) test, substantially reduces the rate of false positives without diminishing test sensitivity, resulting in more accurately predicting ocular irritancy of test substances. More particularly, the disclosed method employs relatively high physiologic concentrations of one or more antioxidants that are normally present in tears. In a variation, much higher concentrations of one or more antioxidants may provide protection against in vivo exposure to ocular irritants.
    Type: Application
    Filed: July 6, 2023
    Publication date: March 14, 2024
    Applicant: Lebrun Labs LLC
    Inventors: Stewart Lebrun, Roxanne Chan, Sara Chavez
  • Publication number: 20230390239
    Abstract: The disclosure relates to formulations and methods for the in vitro testing of ocular irritants. It was discovered that adding an antioxidant formulation to in vitro ocular irritation tests, including for example, a biochemical ocular irritation test, a reconstituted human corneal epithelium (RhCE) ocular irritation test and an excised eye depth of injury (DoI) test, substantially reduces the rate of false positives without diminishing test sensitivity, resulting in more accurately predicting ocular irritancy of test substances. More particularly, the disclosed method employs relatively high physiologic concentrations of one or more antioxidants that are normally present in tears. In a variation, much higher concentrations of one or more antioxidants may provide protection against in vivo exposure to ocular irritants.
    Type: Application
    Filed: July 6, 2023
    Publication date: December 7, 2023
    Applicant: Lebrun Labs LLC
    Inventors: Stewart Lebrun, Roxanne Chan, Sara Chavez
  • Publication number: 20230081986
    Abstract: Disclosed are formulations and procedures to improve the accuracy of nonanimal tests. Disclosed procedures involve both the direct application of the substance to be tested to the excised eye or other suitable test matrix, such as a differentiated tissue, and the application of an aqueous layer to the apical surface and then the addition of the substance to be tested as an overlay to the aqueous layer for a period of time so as to allow metabolism of the substance to be tested by the eye or test matrix, but not so long as to result in nonirritant or nontoxic test substance resulting in a FP result.
    Type: Application
    Filed: August 16, 2022
    Publication date: March 16, 2023
    Applicant: Lebrun Labs LLC
    Inventors: Stewart Lebrun, Linda Nguyen